Vertex’s upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain
.@VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.
Related Articles
Psoriasis: More Than Just the Skin
Many factors make it crucial for pediatricians to understand that psoriasis is not just a skin disease — it can affect children in multiple other…
How Baby Sleep Patterns Change, By Age
Baby sleep is a hot topic for exhausted new parents. Get advice from a pediatrician about how to establish healthy sleep habits so you and…
Google DeepMind releases code behind its most advanced protein prediction program
Six months after backlash, AI company fulfills pledge to make AlphaFold3’s full computer model available for noncommercial use
Trump risks unraveling world order with his Ukraine approach – The Boston Globe
Will Trump concede America’s great source of strength or nourish it?
EU regulator backs Eisai-Biogen Alzheimer’s drug after initial rejection
The European Union’s drugs regulator on Thursday recommended approval of Eisai and Biogen’s Leqembi for some patients with early Alzheimer’s disease, reversing its initial decision…
Women’s Health Two-Day Master Class | Virtual Event
The 2024 Women’s Health Master Class will assemble a consortium of renowned experts in women’s health to dissect intricate clinical challenges and showcase the latest…
Couple who were in NICU at same time as infants were recently married…
archived 10 Nov 2024 14:09:46 UTC
Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular…
Facing a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines
Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.